Skip to main content
HealthReportedMediumDeveloping
4.5

GLP-1 drugs show promise in curbing substance use disorders; new trial launched

A new clinical trial will test GLP-1 weight-loss drugs for their effect on substance use disorders, following promising early results. The study also examines impacts on criminal justice involvement, employment, and housing stability. This expands the potential therapeutic scope of GLP-1s beyond metabolic conditions, though efficacy remains unproven.

STAT Newsabout 20 hours agoUSengCredibility 14%View source

Score Breakdown

Mosaic Score4.5
Model confidence0.3
Significance0.5
Source credibility0.1
Source

Related signals

8 found